SHR-1906 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
85特発性間質性肺炎2

85. 特発性間質性肺炎


臨床試験数 : 627 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05722964
(ClinicalTrials.gov)
February 202311/1/2023Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary FibrosisEfficacy and Safety of Intravenous Infusion of SHR-1906 in Patients With Idiopathic Pulmonary Fibrosis: a Multicenter, Randomized, Double-blind, Parallel Placebo-controlled Phase II TrialIdiopathic Pulmonary FibrosisDrug: SHR-1906;Drug: PlaceboGuangdong Hengrui Pharmaceutical Co., LtdNULLNot yet recruiting40 Years80 YearsAll108Phase 2NULL
2NCT04986540
(ClinicalTrials.gov)
August 10, 202127/7/2021A Trial of SHR - 1906 in Healthy SubjectsA Phase 1, Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single IV Infusion of SHR-1906 in Healthy SubjectsIdiopathic Pulmonary FibrosisDrug: SHR-1906;PlaceboGuangdong Hengrui Pharmaceutical Co., LtdNULLCompleted18 Years55 YearsAll72Phase 1China